Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NCT03133780Phase 2Completed
Phase 2, randomised, double-blind trial of ketamine (2 arms), sponsored by Assiut University. Primary endpoint: Time for the onset of sedation at 90 minutes. Started Jul 2018; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NCT03133780.